Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Visit the company website

 

Bullboard - Investor Discussion Forum Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

TSXV:VM - Post Discussion

Voyageur Pharmaceuticals Ltd > How's that PP coming along?
View:
Post by oldtrouf on Nov 20, 2024 9:46am

How's that PP coming along?

They were suppose to close some of it Nov 5.  Not a good sign.  I will be surprise if they close 30% of it in total.   They will ikely have to extend this measly PP into the new year.  Nobody wants this paper.   Nothing has happened in the last 4 years.  Very disturbing situation  here imo
Comment by Budlight1971 on Nov 20, 2024 5:11pm
I participated 15K
Comment by lscfa on Nov 20, 2024 5:27pm
Good thing co. is producing inventory. Maybe it can get cash deposits from customers to fund production and maybe contract manufacturer can help fund production until things get rolling.
Comment by drongodragon on Nov 20, 2024 6:33pm
Just need news on the last clinical testing. Two months is about up, so hopeful. Might be the jolt the raise needs. 
Comment by JrOGInvestor on Nov 20, 2024 9:03pm
The clinical testing is just a formality, or check in the box if you will. As for two months almost up......halfway there, he mentioned two months in his Oct 29 interview so I wouldn't expect anything until well into December - an early Christmas present perhaps. And as for the earlier comment about being surprised if the close 30 percent of the total by Oldtrout, that's just a black cloud ...more  
Comment by drongodragon on Nov 21, 2024 1:49am
Thanks. Noticed the old trout was a bit fishy. Can't be the first one to say that. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.VM

follow v.vm on


Voyageur Pharmaceuticals Deck 2024..

The Watchlist

Voyageur Pharmaceuticals | The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

COMPELLING
VALUE PROPOSITION

  • Only pharmaceutical company in the world that owns long-term supply of barium and iodine
  • Natural barium and iodine resources meet increasingly limited global supply and risk
  • Multi-billion-dollar global market for contrast media
  • Poised to obtain significant market share by offering high-quality, lower-cost products
  • Favorable regulatory pathway allows rapid commercialization
  • Highly experienced team has positioned the company for profitable commercial success

Contact Us

Brent Willis, CEO
Brent@Vpharma.ca

Address:
Suite 1600 Dome Tower, 333 7th Avenue S.W.
Calgary, Alberta
T2P 2Z1